Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Dear colleagues,
 
The Belgian Early Warning System Drugs (BEWSD) at the Scientific Institute of Public Health (WIV-ISP) would like to report the identification and analysis of several highly dosed ecstasy tablets.
All tablets containing only MDMA were analyzed by the National Institute for Criminology (NICC-INCC - dr. Vanderlinden), while one tablet containing 2C-B was analyzed by the Medicines Department of the WIV-ISP (dr. E. Deconinck).
 
The BEWSD would like to draw your attention specifically to these analysis results and other characteristics, including dosage per tablet, which can be found in the table below.
We take this opportunity to remind you that the majority of ecstasy tablets currently circulating are highly dosed, sometimes containing dosages of up to 300 mg MDMA base
(the purity and MDMA dosage in ecstasy tablets can only be determined using laboratory analysis).
 
Symptoms of a MDMA overdose are characterised by heavy sweating, tremor, dry mouth, nausea, vomiting, elevated blood pressure and heart rate, paranoia and hyperthermia. 
In severe cases, a serotonin syndrome can occur, resulting in an - often fatal - hyperthermia.
Overdose treatment is symptomatic.
 
Please inform your networks.
If you receive multiple copies of these alerts, or if you know of people that do not receive these messages, please send an email to bewsd@wiv-isp.be and we will update our list as soon as possible.
 
Kind regards,
 
Peter